Clinical Trial Update: Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

A multicenter Phase II pilot trial assessing the efficacy and safety of LR-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• LR-CHOP21

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Non Hodgkin Lymphoma, Follicular Lymphoma | Phase 2 | Status: UNKNOWN